Loading...
SARS-CoV-2/COVID-19 in multiple sclerosis patients receiving disease-modifying therapy
At the end of 2019, the COVID-19 pandemic began, which at the time of writing continues to be a serious problem for many areas of medicine, including neurology. Since patients with multiple sclerosis (MS) often exhibit motor disability and receive disease-modifying therapy (DMT), which has an immuno...
Na minha lista:
| Udgivet i: | Clin Neurol Neurosurg |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier B.V.
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7831713/ https://ncbi.nlm.nih.gov/pubmed/33388661 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clineuro.2020.106451 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|